Buy Ranbaxy Laboratories: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Ranbaxy Laboratories.

Sukhani told CNBC-TV18, "Ranbaxy Laboratories has a neat chart. Although unfortunately, it is a V-shaped reversal, we cannot have charts according to our specifications.”

He further added, “It has been consolidating for the last three-four days. For somebody, who likes to watch this stock that way, a bullish head and shoulder pattern, it gives a more ambitious target and perhaps the pharmaceuticals will be the flavour of the next two-three days. So, it is worth buying into. If it is working for you, then carry it."